Impact of Sirflox failure to meet primary end point, page-14

SRX is a failure where as OncoSil has already proven complete response in some patients. Sell off is absurd imo.


Response of HHC Target Tumour after Single Fixed Dose of OncoSilTM
+WHO definitions of tumour response * Denotes investigator’s classification. A change of -100% indicated total disappearance of target lesions
Patient Number % Change in target Tumour Volume Response+ 001 -44% Stable Disease 002 -80% Partial Response 003 -16% Stable Disease 004 -43% Partial Response 005 -100% Complete Response 006 -100% Complete Response 007 -100% Complete Response 008 -35% Stable Disease